ask="4.49"
ask_size="400"
average_daily_volume="283444"
bid="2.15"
bid_size="100"
book_value="3.30"
change="+0.05"
change_from_200_day_moving_average="0.93"
change_from_50_day_moving_average="-0.22"
change_from_52_week_high="-7.01"
change_From_52_week_low="0.48"
change_in_percent="+1.28%"
close="3.97"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.13"
ebitda="-42.86M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.27"
ex_dividend_date="N/A"
float_shares="31676000"
high="3.99"
high_52_weeks="10.98"
last_trade_date="3/17/2017"
last_trade_price="3.97"
last_trade_size="24782"
last_trade_time="4:00pm"
low="3.86"
low_52_weeks="3.49"
market_capitalization="195.41M"
moving_average_200_day="3.04"
moving_average_50_day="4.19"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="3.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+30.72%"
percent_change_from_50_day_moving_average="-5.36%"
percent_change_from_52_week_high="-63.84%"
percent_change_from_52_week_low="+13.75%"
previous_close="3.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.19"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="49221000"
short_ratio="3.80"
stock_exchange="NMS"
symbol="CASC"
volume="191637"
weeks_range_52="3.49 - 10.98"
